SBRX16

SBRX16 is a plant-based drug candidate being developed by Stramsen Biotech for the treatment of neurological disorders, with a primary focus on epilepsy. As part of Stramsen's SBRX series, the compound is derived from the company's proprietary database of medicinal plants and is classified as an herbal medicine. The therapeutic is designed to provide a natural approach to seizure control and neurological management, aiming to work in harmony with the human body's biological processes. While the specific botanical source and molecular mechanism of action remain proprietary and undisclosed, the drug is part of a broader pipeline of natural products being advanced toward clinical evaluation.